Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 5 20 SULFITE FREE IN DEXTROSE 20 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 5 20 SULFITE FREE IN DEXTROSE 20 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER vs KABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Parenteral nutrition formulation providing amino acids (synthetic crystalline L-amino acids), dextrose (carbohydrate calories), and electrolytes. Amino acids support protein synthesis and nitrogen balance; dextrose provides calories to prevent catabolism.
Kabiven is a parenteral nutrition formulation that provides a balanced mixture of amino acids, dextrose, and lipids to meet nutritional requirements. The amino acids serve as building blocks for protein synthesis, dextrose provides a carbohydrate source for energy, and lipids supply essential fatty acids and additional energy. Electrolytes are included to maintain fluid and electrolyte balance.
Intravenous use only. Typical adult dose for maintenance or replacement is 1 to 2 L per day, administered via central or peripheral vein. Contains dextrose 20% with 5% amino acids representing 170 kcal/L from dextrose and 40 g protein/L. Rate of infusion depends on metabolic and clinical needs, generally not to exceed 4 mg/kg/min dextrose.
Intravenous infusion. Adult dose based on nutritional needs: typically 0.8-1.5 g amino acids/kg/day, 0.8-1.5 g lipids/kg/day, and 2-4 g dextrose/kg/day. Maximum infusion rate: 1.7 mL/kg/hour (Kabiven Peripher) or 2.6 mL/kg/hour (Kabiven Central).
None Documented
None Documented
Not applicable as a fixed drug; the components have varying half-lives: amino acids ~1-2 hours, dextrose ~1-2 hours, electrolytes follow physiological kinetics.
Variable; amino acids: 0.5–1 h; lipids: 0.5–1 h (intralipid clearance); glucose: rapid. No true terminal half-life as a mixture.
Renal (primarily as urea, glucose, electrolytes); >90% of infused nitrogen excreted as urea in urine; glucose is metabolized or excreted renally if hyperglycemic; electrolytes follow renal excretion.
Renal: <3% unchanged; primarily metabolized via protein catabolism; nitrogen excretion is renal (urea, ammonia); fat emulsion components are cleared by the reticuloendothelial system and metabolized. Biliary/fecal: negligible.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition